Source: International Congress 2014 – Improving diagnosis of thoracic tumours



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sanchez, J. P. De-Torres, D. O. Wilson, J. Weissfeld, A. Campo, A. B. Alcaide, J. Zulueta (Pamplona, Spain; Pittsburgh, United States Of America). Improving NLST criteria for lung cancer screening. Eur Respir J 2014; 44: Suppl. 58, 352

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Prospective assessment of incidental respiratory symptoms in COPD (PAIRS-COPD), feasibility study Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014